Niven Ralph

Avg. Two Year Performance

No purchase track record
54% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)10%(< 1%)56%54%
Sale Success Rate1 of 22 of 21 of 22 of 22 of 2

Aerovate Therapeutics, Inc.

Other » Other

Chief Scientific Officer:

Holdings: 1.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--